Determination of the dose enhancement exclusively in tumor tissue due to the presence of GNPs.


Journal

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 28 05 2018
revised: 04 11 2018
accepted: 24 11 2018
pubmed: 24 12 2018
medline: 26 7 2019
entrez: 24 12 2018
Statut: ppublish

Résumé

The purpose of this study is to investigate the differences between obtained percentage dose enhancements in areas around nanoparticles in GNPs (gold nanoparticles) enriched medium and percentage dose enhancements in the entire GNPs enriched medium including nanoparticles region. To verify the accuracy of Ir-192 source simulation, the obtained values of air kerma strength, dose rate constants, and radial dose functions were compared against previously published results. Then a 1 cm × 1 cm× 1 cm tumor volume loaded with different diameters of GNPs were considered at a source to the tumor center of 1 cm. Finally, dose enhancements were obtained for 50, 100 and 200 nm GNPs as a function of various concentrations of the radiosensitizer and depth in phantom. Calculations showed that dose enhancement could be customized by varying the size of nanoparticles, concentrations and radial distance from the source. The highest PDE By considering exclusively determination of dose enhancement in the just tumor tissue, calculating (D

Identifiants

pubmed: 30580248
pii: S0969-8043(18)30498-6
doi: 10.1016/j.apradiso.2018.11.013
pii:
doi:

Substances chimiques

Iridium Radioisotopes 0
Iridium-192 0
Radiation-Sensitizing Agents 0
Gold 7440-57-5

Types de publication

Journal Article Validation Study

Langues

eng

Pagination

39-46

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Ali Khodadadi (A)

Department of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Hassan A Nedaie (HA)

Radiation Oncology Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran university of medical sciences, Tehran, Iran. Electronic address: nedaieha@sina.tums.ac.ir.

Mahdi Sadeghi (M)

Medical Physics Department, School of Medicine, Iran University of Medical Science, Tehran, Iran.

Mohammad R Ghassemi (MR)

Accelerators Research, NSTRI, Karaj, Iran.

Asghar Mesbahi (A)

Medical Physics Department, Medical School, Tabriz University of Medical Sciences, Tabriz, Iran.

Nooshin Banaee (N)

Department of Medical Radiation, Engineering Faculty, Central Tehran Branch, Islamic Azad University, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH